Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot
Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
Clinical randomized clinical trial to assess the effectiveness on walking speed of repeated
use of botulinum neurotoxin type A (BoNT/A)in the post-stroke spastic equinovarus foot in
three successive infiltrations at 6-month intervals, checking if the sustainability of the
effect is greater in incobotulinumtoxin A (Xeomin®) than in onabotulinumtoxinA (Botox®).
Phase:
Phase 4
Details
Lead Sponsor:
Parc de Salut Mar
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA